UBS Knock-Out BNTX/ DE000UK16U83 /
08/08/2024 21:06:48 | Chg.-0.010 | Bid21:06:48 | Ask21:06:48 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.200EUR | -0.83% | 1.200 Bid Size: 100,000 |
1.210 Ask Size: 100,000 |
BioNTech SE | 210.8444 USD | 31/12/2078 | Put |
GlobeNewswire
27/06
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire
24/06
BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire
01/06
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire
29/05
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire
28/05
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire
21/05
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire
21/05
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
17/05
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire
17/05
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
09/05
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
22/04
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire
10/04
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire
07/04
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire
28/03
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
20/03
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update